Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

495.89 +2.54 (+0.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,809,683
Open 495.67
Bid (Size) 489.83 (1)
Ask (Size) 505.00 (1)
Prev. Close 493.35
Today's Range 492.29 - 500.25
52wk Range 340.83 - 510.63
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 No-Brainer Stocks to Buy in September
There's at least one key common denominator here: tremendous growth prospects. 
Via The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
These three have secure core businesses, plus multiple paths to grow. 
Via The Motley Fool

Performance

YTD
+20.68%
+20.68%
1 Month
-1.96%
-1.96%
3 Month
+5.47%
+5.47%
6 Month
+16.95%
+16.95%
1 Year
+41.24%
+41.24%

More News

Read More
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Via The Motley Fool
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Via Benzinga
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Via Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
Via Benzinga
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
Via The Motley Fool
Vertex to Participate in Upcoming September Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
Via Benzinga
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Via Benzinga
These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond
Via The Motley Fool
3 Fantastic Growth Stocks to Buy in August
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
Via InvestorPlace
Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them
Via The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in August
Via The Motley Fool
The 3 Best Biotech Stocks to Buy in August 2024
Via InvestorPlace
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
From Vertex Pharmaceuticals
Via Business Wire
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Via The Motley Fool
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
Via The Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.